Comment
Cost effectiveness analysis--assessing the assumptions behind the assumptions
- PMID: 10852296
Item in Clipboard
Comment
Cost effectiveness analysis--assessing the assumptions behind the assumptions
J Rheumatol.
2000 Jun.
No abstract available
Comment on
-
Controversies in economic evaluation in the rheumatic diseases.J Rheumatol. 1999 Sep;26(9):1859-60. J Rheumatol. 1999. PMID: 10493659 No abstract available.
-
The value of utility: assumptions underlying preferences and quality adjusted life years.J Rheumatol. 1999 Sep;26(9):1861-3. J Rheumatol. 1999. PMID: 10493660 Review. No abstract available.
Similar articles
-
Characterizing preferences for health outcomes in economic evaluations.J Rheumatol Suppl. 2003 Dec;68:15-8. J Rheumatol Suppl. 2003. PMID: 14725249 Review. No abstract available.
-
An economic approach to health care.Best Pract Res Clin Rheumatol. 2004 Apr;18(2):203-18. doi: 10.1016/j.berh.2004.02.001. Best Pract Res Clin Rheumatol. 2004. PMID: 15121040 Review.
-
The use of quality-adjusted life-years in cost-effectiveness studies.Allergy. 2006 May;61(5):527-30. doi: 10.1111/j.1398-9995.2006.01053.x. Allergy. 2006. PMID: 16629779 No abstract available.
-
The costs and benefits of enhanced depression care to employers.Arch Gen Psychiatry. 2006 Dec;63(12):1345-53. doi: 10.1001/archpsyc.63.12.1345. Arch Gen Psychiatry. 2006. PMID: 17146009
-
Cost-effectiveness analysis in severe mental illness: outcome measures selection.J Ment Health Policy Econ. 2007 Jun;10(2):101-8. J Ment Health Policy Econ. 2007. PMID: 17603150